Navigation Links
Thomas, McNerney & Partners Expands Team and Moves West Coast Office to San Diego
Date:2/23/2011

SAN DIEGO, Feb. 23, 2011 /PRNewswire/ -- Thomas, McNerney & Partners, LLC, a health care venture capital firm that invests in life science and medical technology companies, will be relocating its West Coast office from San Francisco to San Diego.  Thomas, McNerney partner Pratik Shah, Ph.D. announced the move at BIOCOM's first global partnering conference being held in San Diego.

"Southern California is home to many top-tier scientific and medical centers; it's long been a fertile breeding ground for successful medical technology companies, and it's populated by some of the smartest, most capable people in the country," Dr. Shah said.  "It has all the ingredients that make it an ideal home for Thomas, McNerney's West Coast office." Thomas, McNerney & Partners has ten investments on the West Coast, six of which are in Southern California.

In addition, well known San Diego biopharmaceutical executive Larry Fritz, Ph.D. has joined Thomas, McNerney as an Entrepreneur in Residence and will be based out of the firm's new West Coast office.  Dr. Fritz has founded or co-founded a string of successful biotechnology companies including Athena Neurosciences, Idun, Conforma, Cabrellis and Covella.  He will assist Thomas, McNerney in selecting investments and building companies.  

"Larry has had a long and distinguished career in founding and managing biotechnology companies," said Dr. Shah.  "Importantly, he has been especially successful in creating value for investors and engineering profitable exits in multiple private companies.  Strategically, operationally and scientifically, he is a good fit for the way we do business at Thomas, McNerney, and he will be a great addition to our team."

About Thomas, McNerney & Partners

Thomas, McNerney & Partners is a health care venture capital firm with approximately $600 million under management, focused on investing in life science and medical technology companies at all stages of development.  In addition to helping entrepreneurs launch companies with seed and early stage funding, the firm provides growth capital to emerging companies to advance clinical development or for product commercialization.  Thomas, McNerney & Partners also is involved in spinning out products and divisions from major medical device and pharmaceutical companies, consolidating companies through roll-up strategies and participating in structured financings for public companies, as well as recapitalizations.  The firm has offices in Connecticut, Minnesota and California. For further information, please visit www.tm-partners.com.


'/>"/>
SOURCE Thomas, McNerney & Partners, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Johnson & Johnson to Participate in 2011 Citi Global Health Care Conference
2. Johnson & Johnson Completes Tender Offer for Crucell and Declares Offer Unconditional
3. Smith & Nephews Exclusive OXINIUM™ Material for Hip Replacement Implants Chosen for Premium Reimbursement in Japanese Market
4. Smith & Nephew Enables Minimally Invasive and Anterior Approach Hip Replacement Surgeries With Launch of Modular, Mini Hip Stem
5. Reportlinker Adds U.S. Pain Management Products & Services: a Market Analysis - 7th Edition
6. AT&T Connected Vitality GlowCaps Wins 2011 Global Mobile Award
7. Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds
8. NeoStem to Present at 13th Annual BIO CEO & Investor Conference
9. ADVENTRX Pharmaceuticals to Present at the 13th Annual BIOCEO & Investor Conference on February 15
10. Sutter Health Among the Nations Top Employers According to Readers of CAREERS & the disABLED Magazine
11. Cayenne Medical, Inc. Appoints David B. Springer President & CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now ... of Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Final Cut Pro X users can now reveal the media of their split ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... to revolutionize the emergency ambulance transport experience for the millions of people who ... Uber has disrupted the taxi industry through the use of technology. Now, SmartEMS ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, ... the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where ... city’s history as home to some of the world’s leading providers of cereal and ...
(Date:6/26/2016)... ... ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a weight ... app plans to fix the two major problems leading the fitness industry today:, ... program , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
Breaking Medicine News(10 mins):